Sort
15,273 grants matching “antimicrobial resistance”
GAS Switch from Colonizing Bacterium to Invasive Pathogen
$364,000Victor Nizet · University Of California, San Diego · R01 · FY2018 · AI
GAS Switch from Colonizing Bacterium to Invasive Pathogen
$364,000Victor Nizet · University Of California, San Diego · R01 · FY2016 · AI
GAS Switch from Colonizing Bacterium to Invasive Pathogen
$364,000Victor Nizet · University Of California, San Diego · R01 · FY2019 · AI
GAS Switch from Colonizing Bacterium to Invasive Pathogen
$364,000Victor Nizet · University Of California, San Diego · R01 · FY2017 · AI
The role of redox sensing in Listeria monocytogenes pathogenesis
$363,982Michelle Lynne Reniere · University Of Washington · R01 · FY2021 · AI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential - r
$363,977Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2013 · AI
WHONET: Tools for a Global Microbial Sensor Network
$363,966John Stelling · Brigham And Women'S Hospital · R01 · FY2014 · GM
Oral Mucosal Beta Defensins and HIV
$363,950Case Western Reserve University · R01 · FY2003 · DE
Neutrophil Accumulation in Bacterial Pneumonia
$363,945Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2015 · HL
The causes of balancing selection on immunity genes: from populations to molecular interactions.
$363,937Robert L Unckless · University Of Kansas Lawrence · R01 · FY2021 · AI
Structure and mechanism of the AbgT-family transporters
$363,915Edward W Yu · Iowa State University · R01 · FY2016 · AI
The causes of balancing selection on immunity genes: from populations to molecular interactions.
$363,915Robert L Unckless · University Of Kansas Lawrence · R01 · FY2022 · AI
Non-invasive magnetic nanothermotherapy for resolution of wound biofilm infection
$363,839Min Ho Kim · Kent State University · R01 · FY2018 · NR
TASK X22: Non-GLP Safety Study of multivalent toxoid S. aureus Vaccine (IBT-V02) in nonhuman primates for Integrated Biotherapeutics
$363,829Randi Hornback · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2017 · AI
Drug-eluting joint implants with synergistic antimicrobial release and risk stratified models of preclinical efficacy testing
$363,789Ebru Oral · Massachusetts General Hospital · R01 · FY2022 · AR
Protective Immune Responses to Blastomyces Dermatitidis
$363,750University Of Wisconsin Madison · R01 · FY2005 · AI
Protective Immune Responses to Blastomyces Dermatitidis
$363,750University Of Wisconsin Madison · R01 · FY2004 · AI
Protective Immune Responses to Blastomyces Dermatitidis
$363,750University Of Wisconsin Madison · R01 · FY2003 · AI
Discovery of Novel Nontuberculous Inhibitors
$363,750Elton Jeffrey North · Creighton University · R15 · FY2021 · AI
Protective Immune Responses to Blastomyces Dermatitidis
$363,750University Of Wisconsin Madison · R01 · FY2002 · AI
In Vitro Glycorandomization of Natural Products
$363,740Jon Scott Thorson · University Of Wisconsin-Madison · R01 · FY2007 · AI
Genetic Control of C. albicans Biofilm Formation
$363,733Aaron P Mitchell · Columbia University Health Sciences · R01 · FY2008 · AI
Effect of Bacteria and Mechanical Loading on Degradation of the Composite-Tooth I
$363,598Jack L. Ferracane · Oregon Health & Science University · R01 · FY2011 · DE
Novel non-natural oligomers that mimic the structure and function of bioactive peptides
$363,509Jianfeng Cai · University Of South Florida · R56 · FY2015 · AI
Prevention of C. Albicans Biofilms by Beta-Peptide Release From Thin Films
$363,490Sean P Palecek · University Of Wisconsin-Madison · R01 · FY2011 · AI